Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
Clinical trial NCT05103345 · RECRUITING
Trial details
- NCT number
- NCT05103345
- Sponsor
- Guangzhou Sinogen Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-19
- Primary completion
- 2027-12-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.